Optimizing Transfection to Generate High Titer AAV and Lentiviral Vectors

How LV and AAV Transfection Platforms will Shape the Future of Gene Therapy ManufacturingПодробнее

Enabling Large-Scale Production of Viral Vectors in the Gibco™ CTS LV-MAX Lentiviral....Подробнее

Transient transfection for Lentivirus & AAV production - BPI Interview - Polyplus transfectionПодробнее

High titer adeno-associated virus (AAV) production that is Cost-effective and ScalableПодробнее

Tet-Cell Line Produces High-titer Lentiviral Vectors to target DCs | Protocol PreviewПодробнее

Unlocking the power of AAV and LVV Analytics: Insights and strategies for optimizing viral vector...Подробнее

[Webinar] Advances in gene therapy : next-generation transfection reagent for AAV productionПодробнее

Optimizing AAV vectors with AIПодробнее

Solutions for Viral Vectors: Enabling Platform Approaches to Advance Cell and Gene TherapiesПодробнее

Designing, Packaging & Delivery of High Titer CRISPR Retro & Lentiviruses via Stereotaxic InjectionПодробнее

Key Considerations for Maximizing LV and AAV Production in Transient Transfection WorkflowsПодробнее

The Basics of the Recombinant Lentivirus SystemПодробнее

How to Design, Run, and Optimize A Viral Gene Delivery Experiment - #ResearchersAtWork WebinarПодробнее

Automated parallel AAV characterization with new tools for gene therapyПодробнее

Pre-clinical AAV production and optimization: Not as easy as it looks! | GenScriptПодробнее

Accelerate Cell and Gene Therapy Development and Increase Manufacturing Capacity....Подробнее

Optimizing CAR therapies with DART-AAV vector technologyПодробнее

Webinar: Standardization and Large-scale Manufacturing of Plasmids for Viral Vector ProductionПодробнее

Choosing Between Lentivirus and Adeno associated Virus For DNA DeliveryПодробнее